# NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma

> **NCT06167109** · NA · RECRUITING · sponsor: **Chongqing University Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma by AJCC V8 Stage

## Interventions

- **RADIATION:** CTV optimized IMRT

## Key facts

- **NCT ID:** NCT06167109
- **Lead sponsor:** Chongqing University Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2026-05
- **Final completion:** 2026-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06167109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06167109, "NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06167109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*